ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750227 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750227; 2) Community: the network communities that were significantly associated with the response to NSC 750227; 3) Molecule: the relationships between components within communities and NSC 750227; 4) MDR: the compounds that were significantly associated with the NSC 750227.

NSC Compound Enrichment Correlation
NSC 733654 6-(3-Chloropropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.0438391811600409 0.17337451
NSC 749160 Null 0.0438391811600409 0.14520519
NSC 751830 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one 0.0438391811600412 0.063604262
NSC 758662 Lovastatin [USAN] 0.0438391811600412 0.10148043
NSC 755469 Null 0.045446901295916 0.090234637
NSC 756170 GSK317315A 0.045446901295916 0.23794899
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.045446901295916 -0.27564059
NSC 10848 Null 0.0454469012959173 0.1024904
NSC 111533 Methoxycamptothecin 0.0454469012959173 0.19549845
NSC 111702 p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- 0.0454469012959173 0.24975714
Total:54  Current:43    [First] [Prev] [Next] [Last]